摘要
目的探析莫沙必利联合氟西汀治疗功能性消化不良的临床应用意义并进行分析。方法选取从2015年1月3日~2016年5月31日期间收治的功能性消化不良患者100例作为本次研究的对象,且采取随机均分法分成两组,命名为调研组与对照组。给予对照组莫沙必利治疗;给予调研组莫沙必利联合氟西汀治疗。本次研究的相关数据收集整理并做比较。结果调研组患者采用莫沙必利联合氟西汀治疗的总有效率比单一使用莫沙必利治疗的对照组更加显著(P<0.05),具有统计学意义。两组的不良反应比较(P>0.05),无临床统计学意义。结论莫沙必利联合氟西汀对功能性消化不良的临床效果比单一使用莫沙必利治疗的临床应用效果更明显,且不良反应低,安全性高,值得在临床应用。
Objective To analyze the clinical application of Mosapride combined with fluoxetine in the treatment of func-tional dyspepsia. Methods One hundred cases of patients with functional dyspepsia in our hospital from January 2015 to May 2016 were collected and divided into control group and experimental group. The patients in the control group received mosa-pride treatment, and the patients in the experimental group received mosapride combined with fluoxetine. The data of this study were collected？ collated and compared. Results The total efficiency in the experimental group treated with mosapride combined with fluoxetine was better than the single use ofmosapride treatment in control group, P〈C〇 . 05. The adverse reac-tions in the two groups were compared with P^〉0. 05, and there was no statistical significance. Conclusion Mosapride com-bined with fluoxetine in the treatment of functional dyspepsia had better clinical effect than the single use of the mosapride treatment, with low adverse reaction, high safety, which was worthy of promotion.
出处
《临床研究》
2018年第1期41-42,共2页
Clinical Research
